Loading stock data...
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price, Chart & Analysis
Corbus Pharmaceuticals Holdings, Inc.CRBP
Market Closed$9.25
+$0.00+0.00%
CRBP Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for CRBP to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Loading chart data...
Is Corbus Pharmaceuticals Holdings (CRBP) Stock a Buy in 2025?
YES
BUY
Score: 72/100
Yes, CRBP stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether CRBP stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 339.6% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- High debt-to-equity ratio of 2.21
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$40.67
Upside Potential:339.6%
Investment Summary
CRBP presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 339.6% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 2.21, and consider their own risk tolerance and investment timeline.
Final Recommendation
BUY
Recommendation Score
Overall Score:72/100
Buy
Key Factors
- Very strong analyst buy consensus
- Very significant upside potential
- Wide analyst target range indicates uncertainty
- High debt levels
- Small-cap risks
- Debt-to-Market-Cap Ratio: 2.2% (Very Low)
Investment Decision
Based on our comprehensive analysis of CRBP's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
How to Invest in crbp Stock?
Quick Investment Insights for crbp
High Volatility (Beta: 3.21)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
Biotechnology
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Ne...
Employees
28
Market Cap
$113.36M